Exzeo Group (XZO) Financials

Exzeo Group’s Q2 2026 results show continued year-over-year growth, with revenue, operating income and net income all improving from the comparable quarter. However, the quarter also featured a substantial cash decline as the company continued shifting funds into long-term investments. The data provided covers selected quarters from Q3 2024 through Q2 2026 rather than a complete four-year history.

• Revenue growth continued: Q2 2026 revenue increased to $57.8 million from $56.1 million in Q2 2025, a gain of approximately 3.0%. Revenue also rose 4.1% sequentially from $55.5 million in Q1 2026.
• Margins improved meaningfully: Gross profit rose to $36.8 million, producing a gross margin of approximately 63.7%, compared with 59.8% in Q2 2025 and 59.0% in Q1 2026. Operating margin also improved to approximately 49.3% from 45.1% a year earlier.
• Profitability strengthened: Net income increased to $23.3 million in Q2 2026 from $21.7 million in Q2 2025, while diluted EPS remained at $0.26. Net income was also up from $20.4 million in Q1 2026, and EPS improved from $0.22.
• The company remained highly profitable relative to its size: Q2 operating income was $28.5 million and represented nearly half of revenue. Selling, general and administrative expense increased year over year, but overall operating expenses remained well below gross profit.
• Operating cash flow remained positive: Exzeo generated $15.4 million of operating cash flow in Q2 2026 and approximately $15.2 million after capital expenditures. This indicates that reported earnings continued to convert into cash, despite working-capital pressure during the quarter.
• Leverage appears limited: Total liabilities declined to $97.6 million from $104.8 million in Q1 2026, and Q2 financing cash outflows included $318,000 of debt repayment. Equity increased to $288.2 million, leaving the company with a relatively strong equity cushion.
• Liquidity was reallocated rather than simply consumed: Cash and equivalents fell to $136.7 million from $231.4 million in Q1, but long-term investments rose to $197.1 million from $98.5 million. Cash plus long-term investments therefore remained broadly stable at approximately $333.8 million versus $329.9 million in Q1, although investments may be less immediately liquid than cash.
• Investment activity is now a major capital-allocation factor: Exzeo purchased approximately $99.4 million of investments in Q2 2026, following nearly $99.0 million of purchases in Q1. Investors should monitor the composition, liquidity and returns of these investments because they increasingly affect the balance sheet and cash flow profile.
• Operating cash flow weakened sequentially: Q2 operating cash flow of $15.4 million declined from $25.5 million in Q1 2026 and $37.8 million in Q2 2025. The main drag was an $8.3 million use of cash from changes in operating assets and liabilities, reversing the $10.7 million source recorded in Q1.
• Near-term liquidity ratios deteriorated: Total current assets declined to $169.7 million from $260.9 million in Q1, while current liabilities remained elevated at $91.7 million. The current ratio fell to approximately 1.85 from 2.65, and the decline in cash warrants monitoring even though the broader investment portfolio remains substantial.

Overall, the statements present a company with improving operating performance, strong margins and positive earnings-based cash generation. The principal risks are the sharp quarterly decline in cash, weaker operating cash flow and the increasing concentration of capital in long-term investments. Continued revenue growth and sustained cash conversion will be important for determining whether this capital-allocation strategy enhances shareholder value.